Analyst firms · Mizuho · IQV
Mizuho IQV price target and rating history
IQVIA Holdings Inc. (IQV) · Health Care
Mizuho rates IQVIA Holdings Inc. (IQV) Buy with a $270 price target, as of its latest action on Mar 7, 2022. It has published 3 rating actions on IQV since November 2021, including 0 upgrades and 0 downgrades. Across 5 firms with a IQV price target in the last 12 months, the median target is $213.
- Current rating
- Buy
- Price target
- $270
- Median target, all firms
- $213
- Actions on IQV
- 3
Mizuho price target on IQV
Every Mizuho rating on IQV
- Mar 7, 2022
- Dec 20, 2021
- Nov 18, 2021
How other firms rate IQV
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $345 | Sep 30, 2026 |
| Morgan Stanley | Equal-Weight | $200 | Jun 17, 2026 |
| TD Cowen | Buy | $213 | Mar 9, 2026 |
| Barclays | Overweight | $210 | Mar 6, 2026 |
| RBC Capital Markets | Outperform | $221 | Mar 3, 2026 |
Questions about Mizuho and IQV
- What is Mizuho's price target for IQV?
- Mizuho's latest stated price target for IQVIA Holdings Inc. (IQV) is $270, from its action on Mar 7, 2022.
- What is Mizuho's rating on IQV?
- Mizuho rates IQV Buy, a bullish rating, as of Mar 7, 2022.
- When did Mizuho last change its view on IQV?
- On Mar 7, 2022, Mizuho cuts its price target to $270 from $300, keeps Buy.
- How does Mizuho's IQV target compare with other analysts?
- Across 5 firms with a IQV price target in the last 12 months, the median target is $213.
More IQV rating histories
All Mizuho ratingsIQV news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.